Genetic Technology News

摘要

Chiron Myeloma Drug Candidate Enters Clinicals; AVI Antisense Prostate and Ovarian Cancer Drugs; Cell Genesys Sharpens Its Focus; GTN Strategic Partners; Biotech Financing; Some Important Patents for You To Check. GENE THERAPY BOOSTS SPINAL REPAIR INRATS. Unlike cells that make up many tissues of the body, nerve cells do not normally grow to repair spinal injuries. No effective products are available to treat the debilitating effects of nerve damage and spinal injury that affect an estimated 20,000new patients in the United States and Europe each year. However, Innurex, a gene therapy product being developed by Oxford Biomedica Pic, is able to induce nerve repair in spinal cord injuries and restore both sensory and motor functions in experiments with rat models, the company reported at the 8th Annual Meeting of the American Society of Gene Therapy, June 1 to 5,2005 in St. Louis, MO.